| Literature DB >> 29579109 |
Katrina Alice Southworth Davis1,2, Oliver Bashford2,3, Amelia Jewell2, Hitesh Shetty2, Robert J Stewart1,2, Cathie L M Sudlow4, Matthew Hugo Hotopf1,2.
Abstract
BACKGROUND: Administrative data can be used to support research, such as in the UK Biobank. Hospital Episode Statistics (HES) are national data for England that include contain ICD-10 diagnoses for inpatient mental healthcare episodes, but the validity of these diagnoses for research purposes has not been assessed.Entities:
Mesh:
Year: 2018 PMID: 29579109 PMCID: PMC5868851 DOI: 10.1371/journal.pone.0195002
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Inpatient Hospital Episode Statistics pathway from patient to researcher.
Fig 2Hierarchy diagram showing the diagnoses considered in this study, with different levels of detail.
Fig 3Flow chart of cases used to derive gold-standard diagnoses.
Schizophrenia (ICD-10 F20); wSS = wider schizophrenia spectrum disorder (ICD-10 F21-29); BPAD = bipolar affective disorder (ICD-10 F30-31); depression = unipolar depression (ICD-10 F32-33).
Patient characteristics based on diagnosis in HES record by which they were selected.
| Index HES record diagnosis: | Total | ||||
|---|---|---|---|---|---|
| Number of patients | 72 | 37 | 73 | 67 | |
| Mean age (years) (95% CI) | 49 (47–51) | 50 (46–55) | 54 (51–56) | 54 (51–57) | |
| > 65 years (95% CI) | 11/72 | 6/37 | 21/73 | 17/67 | |
| male gender (95% CI) | 47/72 | 17/37 | 31/73 | 31/67 | |
| White British (95% CI) | 13/72 | 11/37 | 34/73 | 40/67 | |
| Black (95% CI) | 45/72 | 17/37 | 20/73 | 13/67 | |
| Other (95% CI) | 14/72 | 9/37 | 19/73 | 14/67 | |
| N. admissions 2006–2015: median (IQR) | 3 (2–5) | 3 (1–4) | 3 (2–6) | 1 (1–2) | |
| Known for at least nine years (95% CI) | 48/72 | 15/37 | 37/73 | 12/67 |
Abbreviations: IQR = interquartile range, N. admissions = Number of admissions, wSS = wider schizophrenia spectrum.
Agreement rates for index HES diagnosis and research primary diagnosis (index and lifetime) by index HES diagnosis.
Index (strict) refers to exact diagnosisprecipitating admission (3 figure ICD-10 code), Index (category) refers to diagnostic group precipitating admission, Lifetime (category) refers to diagnostic group lifetime occurrence. “Uncertain” refers to the research assessor marking the lifetime diagnosis as being uncertain.
| Index HES diagnosis | |||||
|---|---|---|---|---|---|
| Total | |||||
| n. | 69 | 38 | 69 | 66 | 242 |
| -- Index (strict) | 30/69 | 3/38 | 4/69 | 15/66 | |
| -- Index (category) | 59/69 | 13/38 | 46/69 | 42/66 | |
| -- Lifetime (category) | 65/72 | 14/38 | 55/72 | 49/67 | |
| 26/72 | 27/38 | 32/69 | 37/67 | ||
Abbreviations: wSS = wider schizophrenia spectrum disorders
Rate of secondary diagnoses recorded in HES and found in research diagnosis.
| Index HES diagnosis | |||||
|---|---|---|---|---|---|
| Primary HES diagnosis | Total | ||||
| n. | 69 | 38 | 69 | 66 | 242 |
| Index HES | 5/69 | 2/38 | 6/69 | 2/66 | |
| Research diagnosis | 26/69 | 17/37 | 36/69 | 34/66 | |
Abbreviations: wSS = wider schizophrenia spectrum disorder
Inter-rater reliability for primary diagnoses of index and lifetime formulations in 80 cases (160 formulations).
| Primary diagnosis (categories) | ||||||
|---|---|---|---|---|---|---|
| Total | ||||||
| Assessor 1 diagnoses (index and lifetime) | 63 | 12 | 38 | 27 | 20 | 160 |
| 51/63 | 10/12 | 33/38 | 22/27 | 14/20 | ||
| HES index diagnoses | 58 | 10 | 48 | 44 | Na | 160 |
| 49/58 | 2/10 | 36/48 | 23/44 | Na | ||
| 46/58 | 4/10 | 33/48 | 26/44 | Na | ||
Abbreviations: wSS = wider schizophrenia spectrum disorder, Na = not applicable
Accuracy statistics for algorithms to predict lifetime research diagnosis from multiple HES records, based on review of 246 cases.
Numbers of cases given for each diagnostic group predicted by stated algorithm (explained in methods). PPV = positive predictive value, NPV = negative predictive value.
| F20-31 | |||||
|---|---|---|---|---|---|
| Lifetime research primary diagnosis (reference) | 86 | 51 | 49 | 117 | 168 |
| Ever | 96 | 79 | 75 | 139 | 188 |
| Sensitivity | 78% (69–86) | 91% (81–96) | 84% (72–92) | 90% (84–94) | 93% (88–96) |
| Specificity | 84% (77–89) | 85% (80–90) | 85% (79–89) | 77% (69–84) | 69% (57–79) |
| PPV | 74% (64–82) | 65% (54–75) | 61% (50–71) | 80% (73–86) | 89% (84–93) |
| NPV | 87% (81–91) | 97% (93–99) | 95% (91–97) | 89% (82–94) | 78% (66–87) |
| Agree | 82% (77–86) | 87% (82–90) | 85% (80–89) | 84% (79–88) | 86% (82–90) |
| Cohen’s kappa | 0.61 | 0.67 | 0.60 | 0.68 | 0.65 |
| More than one | 73 | 59 | 42 | 95 | 147 |
| Sensitivity | 66% (56–75) | 77% (64–86) | 44% (32–57) | 66% (57–73) | 76% (69–81) |
| Specificity | 92% (86–95) | 92% (87–95) | 91% (86–94) | 88% (82–93) | 83% (72–90) |
| PPV | 82% (72–89) | 74% (62–83) | 57% (42–71) | 85% (76–91) | 92% (86–95) |
| NPV | 82% (76–87) | 93% (88–96) | 85% (79–89) | 72% (64–79) | 56% (46–65) |
| Agree | 82% (77–86) | 88% (84–92) | 80% (75–85) | 77% (71–82) | 78% (72–82) |
| Cohen’s kappa | 0.60 | 0.68 | 0.38 | 0.54 | 0.51 |
| Last | 71 | 66 | 64 | 111 | 177 |
| Sensitivity | 71% (61–79) | 84% (72–91) | 83% (71–91) | 82% (75–88) | 91% (86–95) |
| Specificity | 96% (91–98) | 90% (85–94) | 90% (85–93) | 92% (86–96) | 81% (70–89) |
| PPV | 91% (82–96) | 72% (60–81) | 70% (58–80) | 91% (84–95) | 93% (88–96) |
| NPV | 85% (79–90) | 95% (91–97) | 95% (91–97) | 84% (77–89) | 77% (66–85) |
| Agree | 87% (82–90) | 89% (84–92) | 88% (84–92) | 87% (82–91) | 89% (84–92) |
| Cohen’s kappa | 0.71 | 0.70 | 0.67 | 0.74 | 0.71 |
| Hierarchy | 96 | 49 | 53 | 139 | 188 |
| Sensitivity | 78% (69–86) | 73% (60–82) | 71% (58–82) | 90% (84–94) | 93% (88–96) |
| Specificity | 84% (77–89) | 96% (92–98) | 93% (88–95) | 77% (69–84) | 69% (57–79) |
| PPV | 74% (64–82) | 85% (72–92) | 73% (60–83) | 80% (73–86) | 89% (84–93) |
| NPV | 87% (81–91) | 92% (87–95) | 92% (87–95) | 89% (82–94) | 78% (66–87) |
| Agree | 82% (77–86) | 91% (86–94) | 88% (83–91) | 84% (79–88) | 86% (82–90) |
| Cohen’s kappa | 0.61 | 0.73 | 0.64 | 0.68 | 0.65 |
| Hierarchy >1 | 73 | 53 | 30 | 92 | 145 |
| Sensitivity | 66% (56–75) | 73% (60–83) | 40% (28–54) | 64% (55–72) | 75% (68–80) |
| Specificity | 92% (86–95) | 94% (90–97) | 96% (92–98) | 89% (83–94) | 83% (72–90) |
| PPV | 82% (72–89) | 79% (66–88) | 73% (55–86) | 86% (77–92) | 92% (86–95) |
| NPV | 82% (76–87) | 92% (87–95) | 85% (80–89) | 71% (63–78) | 55% (45–64) |
| Agree | 82% (77–86) | 89% (85–92) | 84% (78–88) | 77% (71–81) | 77% (71–82) |
| Cohen’s kappa | 0.60 | 0.69 | 0.43 | 0.53 | 0.50 |
| Most (hier) | 78 | 67 | 58 | 116 | 183 |
| Sensitivity | 72% (62–80) | 87% (76–94) | 76% (63–85) | 81% (73–87) | 92% (87–95) |
| Specificity | 92% (86–95) | 91% (86–94) | 92% (87–95) | 88% (81–92) | 75% (63–84) |
| PPV | 83% (73–90) | 74% (62–83) | 72% (59–82) | 87% (80–92) | 91% (86–94) |
| NPV | 85% (79–90) | 96% (92–98) | 93% (88–96) | 82% (75–88) | 77% (65–86) |
| Agree | 84% (79–88) | 90% (86–93) | 88% (83–92) | 84% (79–88) | 87% (83–91) |
| Cohen’s kappa | 0.65 | 0.74 | 0.66 | 0.69 | 0.67 |